Login / Signup

Novel Flowchart Guiding the Non-Surgical and Surgical Management of Peri-Implant Complications: A Narrative Review.

Takahiko ShibaKeiji KomatsuYasuo TakeuchiTatsuro KoyanagiYoichi TaniguchiToru TakagiShogo MaekawaTakahiko NagaiRyota KobayashiShunsuke MatsumuraSayaka KatagiriYuichi IzumiAkira AokiTakanori Iwata
Published in: Bioengineering (Basel, Switzerland) (2024)
Peri-implant diseases, such as peri-implant mucositis and peri-implantitis, are induced by dysbiotic microbiota resulting in the inflammatory destruction of peri-implant tissue. Nonetheless, there has yet to be an established protocol for the treatment of these diseases in a predictable manner, although many clinicians and researchers have proposed various treatment modalities for their management. With the increase in the number of reports evaluating the efficacy of various treatment modalities and new materials, the use of multiple decontamination methods to clean infected implant surfaces is recommended; moreover, the use of hard tissue laser and/or air abrasion techniques may prove advantageous in the future. Limited evidence supports additional effects on clinical improvement in antimicrobial administration for treating peri-implantitis. Implantoplasty may be justified for decontaminating the implant surfaces in the supracrestal area. Surgical treatment is employed for advanced peri-implantitis, and appropriate surgical methods, such as resection therapy or combination therapy, should be selected based on bone defect configuration. This review presents recent clinical advances in debridement methods for contaminated implant surfaces and regenerative materials for treating peri-implant bone defects. It also proposes a new flowchart to guide the treatment decisions for peri-implant disease.
Keyphrases
  • combination therapy
  • soft tissue
  • stem cells
  • oxidative stress
  • heavy metals
  • radiation therapy
  • risk assessment
  • escherichia coli
  • bone marrow
  • biofilm formation
  • bone loss
  • candida albicans
  • adverse drug